Tag: metastatic pancreatic cancer

March 18, 2019

Rafael Pharma Stands Out with Drugs Treating Difficult Cancers

INN spoke with Rafael Pharmaceuticals' CEO about the company's lead drug candidate, CPI-613, and how it's treating difficult cancers.
May 7, 2018

Rexahn Reports First Quarter 2018 Financial Results

Rexahn Pharmaceuticals (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, announced financial...
April 16, 2018

Shire plc : Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Shire (LSE: SHP, NASDAQ: SHPG) the leading global biotechnology company focused on rare diseases announces today that it has entered...
April 9, 2018

Tyme Provides Clinical and Corporate Update for Fiscal Year End 2018

Tyme Technologies (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced a clinical and corporate update for the...
March 12, 2018

Rexahn Pharmaceuticals Reports Full Year 2017 Financial Results

Rexahn Pharmaceuticals (NYSE:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced financial...
March 2, 2018

NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results

NewLink Genetics (NASDAQ:NLNK) reported consolidated financial results for the fourth quarter and year ended 2017, as well as progress in its...
February 7, 2018

Tyme Provides Clinical and Corporate Update for Fiscal Third Quarter 2017

Tyme Technologies (NASDAQ:TYME), a clinical-stage biotechnology company developing cancer therapeutics, today announced a clinical and corporate update for the fiscal...